Company Analysis

SkinHealth Systems Inc. (SKIN)

Nasdaq: SKIN · Surgical & Medical Instruments & Apparatus · Long Beach, CA · filing with the SEC since 2020
Grade4.1
◀ Past 3.5● Present 4.5▶ Future 4.1

Filings

287 filings since 2017 beside 155 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Aug 12, 2026.

Filings a yearinsider forms included
221128769524951
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 19 times in the last 36 months, the newest Sep 10, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest May 12, 2026.A late-filing notice, Form NT 10-K, filed Feb 29, 2024.A late-filing notice, Form NT 10-Q, filed Nov 13, 2023.
Insider forms 155

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 14, 2026 8-K items 3.03, 5.03, 7.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Oct 6, 2026 8-K items 1.02, 7.01 Major agreement ended; Investor disclosure (Regulation FD) · Current report Sep 30, 2026
Sep 28, 2026 8-K item 5.07 Shareholder vote · Current report Sep 22, 2026
Sep 10, 2026 8-K item 5.02 Officer or director change · Current report Sep 3, 2026
Aug 14, 2026 8-K item 5.02 Officer or director change · Current report Aug 10, 2026
Aug 12, 2026 DEFA14A Extra proxy material
Aug 12, 2026 DEF 14A Proxy statement Sep 22, 2026
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 31, 2026 PRE 14A Preliminary proxy statement Sep 22, 2026
Jul 27, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 17, 2026 SCHEDULE 13G Large holder notice
Jul 13, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 8, 2026 SCHEDULE 13G/A Large holder update, amended
Jun 22, 2026 8-K item 8.01 Other event · Current report Jun 17, 2026
Jun 16, 2026 8-K item 5.07 Shareholder vote · Current report Jun 10, 2026
May 21, 2026 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended May 5, 2026
May 12, 2026 8-K item 3.01 Listing warning from its exchange · Current report May 8, 2026
May 11, 2026 SCHEDULE 13D/A Activist holder update, amended
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 8-K item 5.02 Officer or director change · Current report May 5, 2026
May 6, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 24, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 24, 2026 DEF 14A Proxy statement Jun 10, 2026
Apr 22, 2026 8-K items 5.02, 5.03, 7.01, 9.01 Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Apr 17, 2026
Apr 20, 2026 SCHEDULE 13G Large holder notice
Mar 12, 2026 10-K Annual report Dec 31, 2025
Mar 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 6, 2026 8-K items 8.01, 9.01 Other event · Current report Mar 3, 2026
Feb 6, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 5, 2026 SCHEDULE 13G Large holder notice
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 3, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Oct 30, 2025
Oct 17, 2025 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Sep 26, 2025
40 of 287 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SKIN · research, not advice